Incyte Genomics Inc (INCY) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INCY. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 840 institutions reported holding INCY, with 201.2 million shares worth $22.8 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Baker Bros. Advisors | 30,762,330 | $3.5B | INCREASED |
| Vanguard | 20,594,512 | $2.3B | INCREASED |
| BlackRock | 18,032,718 | $2.0B | DECREASED |
| Dodge & Cox | 11,957,326 | $1.4B | DECREASED |
| State Street | 9,722,336 | $1.1B | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Pablo J Cagnoni (President, Global Head of R&D) | EXERCISE | 925 | $59K | 2026-10-15 |
| Pablo J Cagnoni (President, Global Head of R&D) | EXERCISE | 455 | $28K | 2026-10-15 |
| Pablo J Cagnoni (President, Global Head of R&D) | EXERCISE | 423 | $26K | 2026-10-15 |
| Pablo J Cagnoni (President, Global Head of R&D) | EXERCISE | 839 | $60K | 2026-10-15 |
| Pablo J Cagnoni (President, Global Head of R&D) | SELL | 2,642 | $298K | 2026-10-15 |
Recent Congressional Trades
| Member | Type | Amount | Date |
|---|---|---|---|
| Ro Khanna (Democrat) | PURCHASE | $1,001 - $15,000 | 2026-09-04 |
Full institutional holdings, insider history, and congressional trades for Incyte Genomics Inc on SentiSense.